DrugRepo: A novel approach to repurpose a huge collection of compounds based on chemical and genomic features
Wang, Y.; Aldahdooh, J.; hu, y.; Yang, H.; vaha-koskela, M.; Tang, J.; Tanoli, Z.
Show abstract
The drug development process consumes 9-12 years and approximately one billion US dollars in terms of costs. Due to high finances and time costs required by the traditional drug discovery paradigm, repurposing the old drugs to treat cancer and rare diseases is becoming popular. Computational approaches are mainly data-driven and involve a systematic analysis of different data types leading to the formulation of repurposing hypotheses. This study presents a novel scoring algorithm based on chemical and genomic data types to repurpose vast collection of compounds for 674 cancer types and other diseases. The data types used to design the scoring algorithm are chemical structures, drug-target interactions (DTI), pathways, and disease-gene associations. The repurpose scoring algorithm is strengthened by integrating the most comprehensive manually curated datasets for each data type. More than 100 of our repurposed compounds can be matched with ongoing studies at clinical trials (https://clinicaltrials.gov/). Our analysis is supported by a web tool available at: http://drugrepo.org/.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies 97%
- Dr AFC: Drug Repositioning Through Anti-Fibrosis Characteristic 97%
- Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments 96%
Similar papers in this journal
Similar papers in this journal
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 96%
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 96%
- DenovoProfiling: a webserver for de novo generated molecule library profiling 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.